T1	Participants 60 132	adults with soft tissue sarcomas of the head and neck, breast, and trunk
T2	Participants 147 252	31 patients were entered in a randomized, prospective study testing the efficacy of adjuvant chemotherapy
T3	Participants 509 558	Seventeen patients received adjuvant chemotherapy
T4	Participants 1596 1622	entire group of 57 patient
T5	Participants 2031 2095	he subgroup of patients with sarcomas of the trunk (39 patients)
T6	Participants 1684 1731	Local control was achieved in 46 patients (81%)
